Clinical Trials Logo

Clinical Trial Details — Status: Unknown status

Administrative data

NCT number NCT01612572
Other study ID # RSCMI-?
Secondary ID RSCMI- ?
Status Unknown status
Phase N/A
First received June 3, 2012
Last updated June 5, 2012
Start date January 2012
Est. completion date December 2015

Study information

Verified date June 2012
Source China Academy of Chinese Medical Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study was advocated by Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences in October 2011.

It was funded by China major scientific and technological specialized project for 'significant new formulation of new drugs'.

Xiyanping is kind of Chinese Medicine injection used for treating viral pneumonia 、bronchitis、amygdalitis、infantile diarrhea、bacillary dysentery 、virus hepatitis、and Children acute hot diseases in many Chinese hospitals.

The purpose of this study is to determine adverse drug events or adverse drug reaction in large sample size 20,000 patients.


Description:

It is very common that Chinese Medicine Injection used in hospitals in mainland China. However safety problems rose in recent years. There could be many uncertain factors influence Chinese Medicine Injection in clinical practice.

In order to ensure the safety of public drug use and lower drug-induced risks, a registry study for Xiyanping injection safety surveillance with 20000 patients will be conducted from Jan.2012 to Dec.2015.

Eligibility criteria Patients who will use Xiyanping injection in selected hospitals.


Recruitment information / eligibility

Status Unknown status
Enrollment 20000
Est. completion date December 2015
Est. primary completion date December 2014
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- Xiyanping injection from 2012 to 2014

Study Design


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
China Academy of Chinese Medical Sciences

Outcome

Type Measure Description Time frame Safety issue
Primary Number of participants with adverse events; incidence of Xiyanping'ADRs and identify factors that contributed to the occurrence of the adverse reaction The registry procedure will last 3 years only for patients using Xiyanping.
See also
  Status Clinical Trial Phase
Completed NCT04016051 - Acceptance of Clarithromycin in a Straw Compared to Syrup in Children With Upper Respiratory Tract Infections Phase 3
Completed NCT01476995 - Prognostic Indicators as Provided by the EPIC ClearView N/A
Recruiting NCT02913365 - Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis N/A
Completed NCT01033799 - Effect of the Consumption of a Fermented Milk on Common Infections in Shift-workers N/A
Completed NCT00350987 - Procalcitonin Guided Antibiotic Therapy and Hospitalisation in Patients With Lower Respiratory Tract Infections: The "ProHOSP" Study N/A
Completed NCT00250679 - Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease Phase 3
Completed NCT00371527 - Effect of Ipratropium on Acute Bronchitis in Subjects Without Underlying Lung Disease N/A
Completed NCT00042718 - A Study of the Effectiveness and Safety of High Dose, Short-course Levofloxacin in the Treatment of Acute Bacterial Exacerbation (Worsening) of Chronic Bronchitis. Phase 3
Completed NCT02902640 - A Non-Interventional Safety Study of Balsamic Bactrim N/A
Completed NCT02879981 - A Safety Study of Balsamic Bactrim in Pediatric Participants With Acute Bronchitis
Recruiting NCT04144699 - Clinical Validation of Omron WheezeScan
Recruiting NCT03320382 - Multiple Breath Washout, a Clinimetric Dataset
Recruiting NCT04415827 - Energy Supply in Athletes and Untrained Persons With Bronchopulmonary Diseases N/A
Completed NCT01354938 - Outcome Study to Evaluate Klaricid XL® (Clarithromycin Modified Release) in Patients With Acute Exacerbation of Chronic Bronchitis N/A
Completed NCT03535558 - Fluoroquinolone Associated Disability
Recruiting NCT05330637 - Study on the Influence of Climatic and Environmental Factors on Respiratory Diseases in Sanya, Hainan Province, China.
Completed NCT01240174 - Demonstration of Near Zero Antibiotic Prescribing for Acute Bronchitis N/A
Completed NCT01108185 - Evaluation of the Treatment With Klacid®SR in Patients With Lower Respiratory Tract Infection N/A
Completed NCT00011310 - Cardiopulmonary Effects of Particulate Exposure N/A
Completed NCT00415753 - Procalcitonin as a Marker of Bacterial Pneumonia N/A